Wedbush cuts Alphabet price target to $387 from $445, keeps Outperform
Wedbush kept its Outperform rating on Alphabet and lowered the price target 13% to $387 from $445, according to TradingView citing Benzinga data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Wedbush maintained its Outperform rating on Alphabet shares and cut its price target from $445 to $387, a 13.0% reduction. According to TradingView, citing Benzinga data, the stock closed at $321.89 on October 28, and the new target implies an upside of about 20.2%.
Across the five most recent analyst notes on Alphabet over the past 30 days, including those from Truist Securities, Guggenheim, Piper Sandler, KeyBanc and Susquehanna, price targets range from $345 to $450.
why it matters
A price target revision for a large company like Alphabet rarely moves the broader market on its own, but the spread of targets shows that analysts still hold different views on the company's outlook. A price target is not a forecast of where the stock will trade.
tags
instruments
sources
- Wedbush maintains Geron at Outperform, lowers price target to $5 from $6 — TradingView, 29 October 2026 at 14:39 UTC
- Wedbush maintains Alphabet at Outperform, lowers price target to $387 from $445 — TradingView, 29 October 2026 at 14:49 UTC
- Wedbush maintains Bicara Therapeutics at Outperform, lowers price target to $24 from $33 — TradingView, 29 October 2026 at 14:44 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗